These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population. Gupta K, Trocio J, Keshishian A, Zhang Q, Dina O, Mardekian J, Nadkarni A, Shank TC. BMC Cardiovasc Disord; 2019 Jun 13; 19(1):142. PubMed ID: 31195999 [Abstract] [Full Text] [Related]
4. Real-World Comparative Effectiveness, Safety, and Health Care Costs of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients in the U.S. Department of Defense Population. Gupta K, Trocio J, Keshishian A, Zhang Q, Dina O, Mardekian J, Rosenblatt L, Liu X, Hede S, Nadkarni A, Shank T. J Manag Care Spec Pharm; 2018 Nov 13; 24(11):1116-1127. PubMed ID: 30212268 [Abstract] [Full Text] [Related]
7. Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity. Dhamane AD, Ferri M, Keshishian A, Russ C, Atreja N, Gutierrez C, Emir B, Yuce H, Di Fusco M. Adv Ther; 2023 Mar 13; 40(3):887-902. PubMed ID: 36527598 [Abstract] [Full Text] [Related]
8. Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients. Deitelzweig S, Keshishian A, Li X, Kang A, Dhamane AD, Luo X, Balachander N, Rosenblatt L, Mardekian J, Pan X, Nadkarni A, Di Fusco M, Garcia Reeves AB, Yuce H, Lip GYH. J Am Geriatr Soc; 2019 Aug 13; 67(8):1662-1671. PubMed ID: 31112292 [Abstract] [Full Text] [Related]
9. A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population. Amin A, Keshishian A, Trocio J, Dina O, Le H, Rosenblatt L, Liu X, Mardekian J, Zhang Q, Baser O, Nadkarni A, Vo L. J Manag Care Spec Pharm; 2020 May 13; 26(5):639-651. PubMed ID: 32347184 [Abstract] [Full Text] [Related]
12. Clinical and Economic Outcomes Among Nonvalvular Atrial Fibrillation Patients With Coronary Artery Disease and/or Peripheral Artery Disease. Lopes RD, Thomas L, Di Fusco M, Keshishian A, Luo X, Li X, Masseria C, Friend K, Mardekian J, Pan X, Yuce H, Jones WS. Am J Cardiol; 2021 Jun 01; 148():69-77. PubMed ID: 33667438 [Abstract] [Full Text] [Related]
13. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease. Lopes RD, Steffel J, Di Fusco M, Keshishian A, Luo X, Li X, Masseria C, Hamilton M, Friend K, Gupta K, Mardekian J, Pan X, Baser O, Jones WS. Am J Med; 2018 Sep 01; 131(9):1075-1085.e4. PubMed ID: 29807001 [Abstract] [Full Text] [Related]
18. Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation. Jansson M, Själander S, Sjögren V, Björck F, Renlund H, Norrving B, Själander A. J Thromb Thrombolysis; 2023 Apr 01; 55(3):415-425. PubMed ID: 36607464 [Abstract] [Full Text] [Related]